Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 184

1.

Antidepressants and the risk of death in older patients with depression: A population-based cohort study.

Kollhorst B, Jobski K, Krappweis J, Schink T, Garbe E, Schmedt N.

PLoS One. 2019 Apr 15;14(4):e0215289. doi: 10.1371/journal.pone.0215289. eCollection 2019.

2.

Impfen bei Immundefizienz : Anwendungshinweise zu den von der Ständigen Impfkommission empfohlenen Impfungen. (IV) Impfen bei Autoimmunkrankheiten, bei anderen chronisch-entzündlichen Erkrankungen und unter immunmodulatorischer Therapie.

Wagner N, Assmus F, Arendt G, Baum E, Baumann U, Bogdan C, Burchard G, Föll D, Garbe E, Hecht J, Müller-Ladner U, Niehues T, Überla K, Vygen-Bonnet S, Weinke T, Wiese-Posselt M, Wojcinski M, Zepp F.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2019 Apr;62(4):494-515. doi: 10.1007/s00103-019-02905-1. German. No abstract available.

PMID:
30899964
3.

Background paper to the decision to recommend the vaccination with the inactivated herpes zoster subunit vaccine : Statement of the German Standing Committee on Vaccination (STIKO) at the Robert Koch Institute.

Siedler A, Koch J, Garbe E, Hengel H, von Kries R, Ledig T, Mertens T, Zepp F, Überla K.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2019 Mar;62(3):352-376. doi: 10.1007/s00103-019-02882-5. No abstract available.

PMID:
30848293
4.

Risk of acute myocardial infarction during use of individual NSAIDs: A nested case-control study from the SOS project.

Masclee GMC, Straatman H, Arfè A, Castellsague J, Garbe E, Herings R, Kollhorst B, Lucchi S, Perez-Gutthann S, Romio S, Schade R, Schink T, Schuemie MJ, Scotti L, Varas-Lorenzo C, Valkhoff VE, Villa M, Sturkenboom MCJM.

PLoS One. 2018 Nov 1;13(11):e0204746. doi: 10.1371/journal.pone.0204746. eCollection 2018.

5.

Risk of ischemic stroke and the use of individual non-steroidal anti-inflammatory drugs: A multi-country European database study within the SOS Project.

Schink T, Kollhorst B, Varas Lorenzo C, Arfè A, Herings R, Lucchi S, Romio S, Schade R, Schuemie MJ, Straatman H, Valkhoff V, Villa M, Sturkenboom M, Garbe E.

PLoS One. 2018 Sep 19;13(9):e0203362. doi: 10.1371/journal.pone.0203362. eCollection 2018.

6.

Sodium-glucose co-transporter-2 inhibitors and the risk of fractures of the upper or lower limbs in patients with type 2 diabetes: A nested case-control study.

Schmedt N, Andersohn F, Walker J, Garbe E.

Diabetes Obes Metab. 2019 Jan;21(1):52-60. doi: 10.1111/dom.13480. Epub 2018 Aug 28.

PMID:
30047217
7.

Targeted resequencing of a locus for heparin-induced thrombocytopenia on chromosome 5 identified in a genome-wide association study.

Witten A, Bolbrinker J, Barysenka A, Huber M, Rühle F, Nowak-Göttl U, Garbe E, Kreutz R, Stoll M.

J Mol Med (Berl). 2018 Aug;96(8):765-775. doi: 10.1007/s00109-018-1661-6. Epub 2018 Jun 22.

PMID:
29934777
8.
9.

Use and Characteristics of Antipsychotic/Methylphenidate Combination Therapy in Children and Adolescents with a Diagnosis of Attention-Deficit/Hyperactivity Disorder.

Scholle O, Banaschewski T, Enders D, Garbe E, Riedel O.

J Child Adolesc Psychopharmacol. 2018 Jul/Aug;28(6):415-422. doi: 10.1089/cap.2018.0024. Epub 2018 May 16.

PMID:
29768038
10.

Tracking the elusive 5' exonuclease activity of Chlamydomonas reinhardtii RNase J.

Liponska A, Jamalli A, Kuras R, Suay L, Garbe E, Wollman FA, Laalami S, Putzer H.

Plant Mol Biol. 2018 Apr;96(6):641-653. doi: 10.1007/s11103-018-0720-2. Epub 2018 Mar 29.

PMID:
29600502
11.

The contribution of comorbidities to mortality in hospitalized patients with heart failure.

Riedel O, Ohlmeier C, Enders D, Elsässer A, Vizcaya D, Michel A, Eberhard S, Schlothauer N, Berg J, Garbe E.

Clin Res Cardiol. 2018 Jun;107(6):487-497. doi: 10.1007/s00392-018-1210-x. Epub 2018 Feb 5.

PMID:
29404680
12.

The Risk of Hospitalizations with Injury Diagnoses in a Matched Cohort of Children and Adolescents with and without Attention Deficit/Hyperactivity Disorder in Germany: A Database Study.

Lindemann C, Langner I, Banaschewski T, Garbe E, Mikolajczyk RT.

Front Pediatr. 2017 Oct 24;5:220. doi: 10.3389/fped.2017.00220. eCollection 2017.

13.

Drug-induced kidney injury: A large case series from the Berlin Case-Control Surveillance Study
.

Douros A, Bronder E, Klimpel A, Erley C, Garbe E, Kreutz R.

Clin Nephrol. 2018 Jan;89 (2018)(1):18-26. doi: 10.5414/CN109212.

PMID:
29035197
14.

Extent and risks of antidepressant off-label use in children and adolescents in Germany between 2004 and 2011.

Schröder C, Dörks M, Kollhorst B, Blenk T, Dittmann RW, Garbe E, Riedel O.

Pharmacoepidemiol Drug Saf. 2017 Nov;26(11):1395-1402. doi: 10.1002/pds.4289. Epub 2017 Aug 24.

PMID:
28840629
15.

Extent and Risks of Antipsychotic Off-Label Use in Children and Adolescents in Germany Between 2004 and 2011.

Schröder C, Dörks M, Kollhorst B, Blenk T, Dittmann RW, Garbe E, Riedel O.

J Child Adolesc Psychopharmacol. 2017 Nov;27(9):806-813. doi: 10.1089/cap.2016.0202. Epub 2017 Jun 15.

PMID:
28618239
16.

Immobilization and high platelet count are associated with thromboembolic complications in heparin-induced thrombocytopenia.

Bolbrinker J, Garbe E, Douros A, Huber M, Bronder E, Klimpel A, Andersohn F, Meyer O, Salama A, Kreutz R.

Pharmacoepidemiol Drug Saf. 2017 Oct;26(10):1149-1155. doi: 10.1002/pds.4235. Epub 2017 May 24.

PMID:
28544026
17.

Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data.

Bally M, Dendukuri N, Rich B, Nadeau L, Helin-Salmivaara A, Garbe E, Brophy JM.

BMJ. 2017 May 9;357:j1909. doi: 10.1136/bmj.j1909. Review.

18.

Use of azithromycin and risk of ventricular arrhythmia.

Trifirò G, de Ridder M, Sultana J, Oteri A, Rijnbeek P, Pecchioli S, Mazzaglia G, Bezemer I, Garbe E, Schink T, Poluzzi E, Frøslev T, Molokhia M, Diemberger I, Sturkenboom MCJM.

CMAJ. 2017 Apr 18;189(15):E560-E568. doi: 10.1503/cmaj.160355.

19.

From prescription-only (Rx) to over-the-counter (OTC) status in Germany 2006-2015: pharmacological perspectives on regulatory decisions.

Barrenberg E, Garbe E.

Eur J Clin Pharmacol. 2017 Jul;73(7):901-910. doi: 10.1007/s00228-017-2240-4. Epub 2017 Mar 28.

PMID:
28352949
20.

Initiation and duration of dual antiplatelet therapy after inpatient percutaneous coronary intervention with stent implantation in Germany: An electronic healthcare database cohort study.

Luque Ramos A, Ohlmeier C, Enders D, Linder R, Horenkamp-Sonntag D, Prochaska JH, Mikolajczyk R, Garbe E.

Z Evid Fortbild Qual Gesundhwes. 2017 Feb;120:31-38. doi: 10.1016/j.zefq.2016.12.007. Epub 2017 Feb 7.

PMID:
28284365
21.
22.

Characterization of new users of cilostazol in the UK, Spain, Sweden, and Germany.

Castellsague J, Perez-Gutthann S, Calingaert B, Bui C, Varas-Lorenzo C, Arana A, Prados-Torres A, Poblador-Plou B, Gonzalez-Rubio F, Giner-Soriano M, Roso-Llorach A, Linder M, Citarella A, Scholle O, Blenk T, Garbe E.

Pharmacoepidemiol Drug Saf. 2017 Jun;26(6):615-624. doi: 10.1002/pds.4167. Epub 2017 Jan 30.

23.
24.

Risk of Stroke after Herpes Zoster - Evidence from a German Self-Controlled Case-Series Study.

Schink T, Behr S, Thöne K, Bricout H, Garbe E.

PLoS One. 2016 Nov 23;11(11):e0166554. doi: 10.1371/journal.pone.0166554. eCollection 2016.

25.

Outpatient antidepressant drug use in children and adolescents in Germany between 2004 and 2011.

Schröder C, Dörks M, Kollhorst B, Blenk T, Dittmann RW, Garbe E, Riedel O.

Pharmacoepidemiol Drug Saf. 2017 Feb;26(2):170-179. doi: 10.1002/pds.4138. Epub 2016 Nov 20.

PMID:
27868277
26.

Hintergrundpapier der STIKO: Evaluation der bestehenden Influenzaimpfempfehlung für Indikationsgruppen und für Senioren (Standardimpfung ab 60 Jahren).

Remschmidt C, Harder T, Wichmann O, Garbe E, Ledig T, Terhardt M, Wicker S, Zepp F, Mertens T.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2016 Dec;59(12):1606-1622. German. No abstract available.

PMID:
27815578
27.

Tocilizumab-induced pancreatitis: case report and review of data from the FDA Adverse Event Reporting System.

Flaig T, Douros A, Bronder E, Klimpel A, Kreutz R, Garbe E.

J Clin Pharm Ther. 2016 Dec;41(6):718-721. doi: 10.1111/jcpt.12456. Epub 2016 Sep 27.

PMID:
27670839
28.

Characteristics and drug use patterns of older antidepressant initiators in Germany.

Jobski K, Schmedt N, Kollhorst B, Krappweis J, Schink T, Garbe E.

Eur J Clin Pharmacol. 2017 Jan;73(1):105-113. doi: 10.1007/s00228-016-2145-7. Epub 2016 Oct 18.

PMID:
27752752
29.

Frequency and trends of disease-modifying antirheumatic drug (DMARD) use in Germany.

Fassmer AM, Garbe E, Schmedt N.

Pharmacol Res Perspect. 2016 Sep 27;4(5):e00254. eCollection 2016 Oct.

30.

Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control study.

Arfè A, Scotti L, Varas-Lorenzo C, Nicotra F, Zambon A, Kollhorst B, Schink T, Garbe E, Herings R, Straatman H, Schade R, Villa M, Lucchi S, Valkhoff V, Romio S, Thiessard F, Schuemie M, Pariente A, Sturkenboom M, Corrao G; Safety of Non-steroidal Anti-inflammatory Drugs (SOS) Project Consortium.

BMJ. 2016 Sep 28;354:i4857. doi: 10.1136/bmj.i4857.

31.

Outpatient antipsychotic drug use in children and adolescents in Germany between 2004 and 2011.

Schröder C, Dörks M, Kollhorst B, Blenk T, Dittmann RW, Garbe E, Riedel O.

Eur Child Adolesc Psychiatry. 2017 Apr;26(4):413-420. doi: 10.1007/s00787-016-0905-7. Epub 2016 Sep 13.

PMID:
27623818
32.

Comparative risk of death in older adults treated with antipsychotics: A population-based cohort study.

Schmedt N, Kollhorst B, Enders D, Jobski K, Krappweis J, Garbe E, Schink T.

Eur Neuropsychopharmacol. 2016 Sep;26(9):1390-1400. doi: 10.1016/j.euroneuro.2016.07.006. Epub 2016 Jul 27.

PMID:
27475994
33.

[Pharmacovigilance in Germany : It is about time].

Douros A, Schaefer C, Kreutz R, Garbe E.

Internist (Berl). 2016 Jun;57(6):616-23. doi: 10.1007/s00108-016-0068-0. Review. German.

PMID:
27224991
34.

Risk of venous thromboembolism in cancer patients treated with epoetins or blood transfusions.

Douros A, Jobski K, Kollhorst B, Schink T, Garbe E.

Br J Clin Pharmacol. 2016 Sep;82(3):839-48. doi: 10.1111/bcp.13019. Epub 2016 Jun 22.

35.

[Percutaneous coronary interventions : Use between 2004 and 2012 in Germany].

Ohlmeier C, Czwikla J, Enders D, Mikolajczyk R, Blindt R, Horenkamp-Sonntag D, Linder R, Garbe E.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2016 Jun;59(6):783-8. doi: 10.1007/s00103-016-2352-5. Review. German.

PMID:
27188620
36.

[Optimizing ADHD Treatment? Results of a Pilotstudy of the ADHD Selective Contract in Bremerhaven, Germany].

Kersting C, Lindemann C, Mikolajczyk R, Garbe E, Riedel O.

Psychother Psychosom Med Psychol. 2016 May;66(5):187-94. doi: 10.1055/s-0042-100814. Epub 2016 Apr 27. German.

PMID:
27119358
37.

Prescribing pattern of antipsychotic drugs during the years 1996-2010: a population-based database study in Europe with a focus on torsadogenic drugs.

Oteri A, Mazzaglia G, Pecchioli S, Molokhia M, Ulrichsen SP, Pedersen L, Poluzzi E, De Ponti F, Garbe E, Schink T, Herings R, Bezemer ID, Sturkenboom MC, Trifirò G.

Br J Clin Pharmacol. 2016 Aug;82(2):487-97. doi: 10.1111/bcp.12955. Epub 2016 May 18. Erratum in: Br J Clin Pharmacol. 2017 Jun;83(6):1360.

38.

Validating mortality in the German Pharmacoepidemiological Research Database (GePaRD) against a mortality registry.

Ohlmeier C, Langner I, Garbe E, Riedel O.

Pharmacoepidemiol Drug Saf. 2016 Jul;25(7):778-84. doi: 10.1002/pds.4005. Epub 2016 Apr 7.

PMID:
27061445
39.

Treatment patterns and characteristics of older antipsychotic users in Germany.

Schmedt N, Jobski K, Kollhorst B, Krappweis J, Rüther E, Schink T, Garbe E.

Int Clin Psychopharmacol. 2016 May;31(3):159-69. doi: 10.1097/YIC.0000000000000119.

PMID:
26871678
40.

Herb-Induced Liver Injury in the Berlin Case-Control Surveillance Study.

Douros A, Bronder E, Andersohn F, Klimpel A, Kreutz R, Garbe E, Bolbrinker J.

Int J Mol Sci. 2016 Jan 15;17(1). pii: E114. doi: 10.3390/ijms17010114.

41.

Estimating the prevalence of Parkinson's disease (PD) and proportions of patients with associated dementia and depression among the older adults based on secondary claims data.

Riedel O, Bitters D, Amann U, Garbe E, Langner I.

Int J Geriatr Psychiatry. 2016 Aug;31(8):938-43. doi: 10.1002/gps.4414. Epub 2016 Jan 14.

PMID:
26764603
42.

The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project.

Raschi E, Poluzzi E, Salvo F, Koci A, Suling M, Antoniazzi S, Perina L, Hazell L, Moretti U, Sturkenboom M, Garbe E, Pariente A, De Ponti F.

Drug Saf. 2016 Jan;39(1):59-68. doi: 10.1007/s40264-015-0353-1.

43.

Response to comment on: "antibiotic use varies substantially among adults--a cross‑national study from five European Countries in the ARITMO project".

Mor A, Thomsen RW, Frøslev T, Garbe E, Poluzzi E, Sturkenboom MC, Trifirò G, Søgaard M.

Infection. 2016 Feb;44(1):135-41. doi: 10.1007/s15010-015-0829-z. Epub 2015 Sep 16. No abstract available.

PMID:
26377832
44.

Erratum to: Antibiotic use varies substantially among adults: a cross-national study from five European Countries in the ARITMO project.

Mor A, Frøslev T, Thomsen RW, Oteri A, Rijnbeek P, Schink T, Garbe E, Pecchioli S, Innocenti F, Bezemer I, Poluzzi E, Sturkenboom MC, Trifirò G, Søgaard M.

Infection. 2016 Feb;44(1):145-50. doi: 10.1007/s15010-015-0835-1. No abstract available.

PMID:
26358972
45.

Use of over-the-counter (OTC) drugs and perceptions of OTC drug safety among German adults.

Barrenberg E, Garbe E.

Eur J Clin Pharmacol. 2015 Nov;71(11):1389-96. doi: 10.1007/s00228-015-1929-5. Epub 2015 Aug 25.

PMID:
26300207
46.

Comparison of basal insulin therapies with regard to the risk of acute myocardial infarction in patients with type 2 diabetes: an observational cohort study.

Kollhorst B, Behr S, Enders D, Dippel FW, Theobald K, Garbe E.

Diabetes Obes Metab. 2015 Dec;17(12):1158-65. doi: 10.1111/dom.12554. Epub 2015 Oct 5.

PMID:
26279482
47.
48.

[Benefits of large healthcare databases for drug risk research].

Garbe E, Pigeot I.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2015 Aug;58(8):829-837. doi: 10.1007/s00103-015-2185-7. German.

PMID:
26092163
49.

Mortality in the German Pharmacoepidemiological Research Database (GePaRD) compared to national data in Germany: results from a validation study.

Ohlmeier C, Langner I, Hillebrand K, Schmedt N, Mikolajczyk R, Riedel O, Garbe E.

BMC Public Health. 2015 Jun 20;15:570. doi: 10.1186/s12889-015-1943-7.

50.

Trends in paediatric macrolide use in five European countries-a population-based study.

Holstiege J, Enders D, Schink T, Innocenti F, Oteri A, Bezemer I, Kaguelidou F, Molokhia M, Poluzzi E, Puccini A, Ulrichsen SP, Sturkenboom MC, Trifirò G, Garbe E.

Eur J Clin Pharmacol. 2015 Aug;71(8):991-9. doi: 10.1007/s00228-015-1870-7. Epub 2015 May 22.

PMID:
25998220

Supplemental Content

Support Center